DK0787491T3 - Middel til forebyggelse og behandling af allergiske sygdomme af type I - Google Patents

Middel til forebyggelse og behandling af allergiske sygdomme af type I

Info

Publication number
DK0787491T3
DK0787491T3 DK95933609T DK95933609T DK0787491T3 DK 0787491 T3 DK0787491 T3 DK 0787491T3 DK 95933609 T DK95933609 T DK 95933609T DK 95933609 T DK95933609 T DK 95933609T DK 0787491 T3 DK0787491 T3 DK 0787491T3
Authority
DK
Denmark
Prior art keywords
branched
linear
allergic diseases
type
remedy
Prior art date
Application number
DK95933609T
Other languages
Danish (da)
English (en)
Inventor
Yukio Amano
Yuko Mizushima
Kenji Ogata
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of DK0787491T3 publication Critical patent/DK0787491T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK95933609T 1994-10-17 1995-10-04 Middel til forebyggelse og behandling af allergiske sygdomme af type I DK0787491T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25029394 1994-10-17
PCT/JP1995/002027 WO1996011682A1 (fr) 1994-10-17 1995-10-04 Composition preventive et remede pour les maladies allergiques de type i

Publications (1)

Publication Number Publication Date
DK0787491T3 true DK0787491T3 (da) 2000-10-16

Family

ID=17205757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95933609T DK0787491T3 (da) 1994-10-17 1995-10-04 Middel til forebyggelse og behandling af allergiske sygdomme af type I

Country Status (19)

Country Link
US (1) US5814649A (hu)
EP (1) EP0787491B1 (hu)
KR (1) KR100365064B1 (hu)
AT (1) ATE194912T1 (hu)
AU (1) AU695907B2 (hu)
CA (1) CA2202904C (hu)
DE (1) DE69518159T2 (hu)
DK (1) DK0787491T3 (hu)
ES (1) ES2148561T3 (hu)
FI (1) FI971584A (hu)
GR (1) GR3034413T3 (hu)
HU (1) HU222888B1 (hu)
IL (1) IL115617A (hu)
NO (1) NO315928B1 (hu)
NZ (1) NZ293691A (hu)
PT (1) PT787491E (hu)
TW (1) TW429146B (hu)
WO (1) WO1996011682A1 (hu)
ZA (1) ZA958708B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
DE69937045T2 (de) 1998-02-19 2008-05-29 Kowa Co., Ltd., Nagoya Cyclische amidderivate
US6303652B1 (en) * 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
WO2001051008A2 (en) * 2000-01-07 2001-07-19 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
US6849260B2 (en) 2000-08-18 2005-02-01 Amgen Inc. Methods and compositions for treating IgE-related disease using NNT-1 inhibitors
AU2001236361A1 (en) * 2000-10-20 2002-05-06 Parker Hughes Institute Treatment of asthma with lfm analogues
US6706703B2 (en) 2001-06-29 2004-03-16 Kowa Co., Ltd. Bis(5-aryl-2-pyridyl) derivatives
US6890940B2 (en) 2001-06-29 2005-05-10 Kowa Co., Ltd. Bis(2-aryl-5-pyridyl) derivatives
US8283515B2 (en) 2002-05-03 2012-10-09 Sca Hygiene Products Ab Absorbent article containing a skin conditioning agent
PE20121478A1 (es) 2009-09-18 2012-11-12 Sanofi Sa Formulaciones en comprimido de teriflunomida: "(4'-trifluorometilfenil) amida del acido (z)-2-ciano-3-hidroxibut-2-enoico con estabilidad mejorada

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
TW314467B (hu) * 1993-03-31 1997-09-01 Hoechst Ag

Also Published As

Publication number Publication date
FI971584A0 (fi) 1997-04-15
US5814649A (en) 1998-09-29
WO1996011682A1 (fr) 1996-04-25
FI971584A (fi) 1997-04-15
CA2202904A1 (en) 1996-04-25
TW429146B (en) 2001-04-11
AU3618695A (en) 1996-05-06
NZ293691A (en) 1999-07-29
EP0787491B1 (en) 2000-07-26
IL115617A0 (en) 1996-01-19
IL115617A (en) 1999-11-30
DE69518159D1 (de) 2000-08-31
GR3034413T3 (en) 2000-12-29
NO971743L (no) 1997-04-16
HUT77135A (hu) 1998-03-02
EP0787491A4 (en) 1998-09-30
NO315928B1 (no) 2003-11-17
KR100365064B1 (ko) 2003-04-11
PT787491E (pt) 2000-11-30
DE69518159T2 (de) 2002-01-03
KR970706811A (ko) 1997-12-01
EP0787491A1 (en) 1997-08-06
ZA958708B (en) 1996-05-14
HU222888B1 (hu) 2003-12-29
ATE194912T1 (de) 2000-08-15
CA2202904C (en) 2006-12-19
ES2148561T3 (es) 2000-10-16
NO971743D0 (no) 1997-04-16
AU695907B2 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
MY107740A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
TW430660B (en) Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
DK0759295T3 (da) Anvendelse af adamantan-derivater til behandling af tinnitus
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DK0787491T3 (da) Middel til forebyggelse og behandling af allergiske sygdomme af type I
DE69707372D1 (de) Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
ATE266027T1 (de) Optisch aktives pyridyl-4h-1,2,4-oxadiazinderivat und seine verwendung zur behandlung von gefässkrankheiten
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE60034545D1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
DK1353660T3 (da) Anvendelse af substituerede 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
NO941478L (no) Ny forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse
IS6416A (is) Fjórgild ammóníum og notkun þeirra sem miðlar gegn hósta
ES2183636T3 (es) 4&#39;-sustituido-4&#39;, 5&#39;-dihidropsoralenos y sus usos terapeuticos.